ImmuCell Corporation

(ICCC) Trade

By |

Profile

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies.

Contact Information

Website: www.immucell.com
Email: mail@immucell.com
Main Phone: +1 207 878-2770
Address: 56 Evergreen Drive
State: ME
City / Town: Portland
Country: USA
Postal Code: 04103

Issuer Information

Exchange: NSC
CEO: Micheal F. Brigham
Employees: 53
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 7.20 $ -0.26 (-3.49%)
Last Price 7.20 Change $ -0.26 Change % -3.49 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 7.40 High 7.40 Low 7.20 Prev Close 7.46
Last Trade Volume 9,942 52 Wk Hi 9.30 52 Wk Low 6.50
Market Cap 39.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 5,485,000.00 EPS (TTM) -0.28 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 1
Number of Buys 0 1
Number of Sells 0 0
Net Activity 0 170000
Last 10 Buys Shares
Norman H Pessin 1,000
David S. Tomsche 1,000
David S. Tomsche 1,000
David S. Tomsche 1,000
David S. Tomsche 1,000
David S. Tomsche 1,000
David S. Tomsche 1,000
David S. Cunningham 1,000
David S. Tomsche 1,000
Linda Rhodes 1,000
Last 10 Sell Shares
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000
Joseph H. Crabb 1,000